Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03136406
Title QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NantCell, Inc.
Indications

pancreatic cancer

Therapies

GI-4000

Leucovorin

Avelumab

Nab-paclitaxel

Bevacizumab

Cyclophosphamide

Capecitabine

Oxaliplatin

Fluorouracil

ETBX-011

ALT-803

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.